AllSquare Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$5.47K Hold
100
﹤0.01% 431
2025
Q2
$5.31K Hold
100
﹤0.01% 433
2025
Q1
$4.33K Hold
100
﹤0.01% 441
2024
Q4
$5.62K Hold
100
﹤0.01% 426
2024
Q3
$6.81K Hold
100
﹤0.01% 411
2024
Q2
$4.22K Hold
100
﹤0.01% 437
2024
Q1
$6.91K Hold
100
﹤0.01% 404
2023
Q4
$7.4K Hold
100
﹤0.01% 396
2023
Q3
$6.82K Hold
100
﹤0.01% 399
2023
Q2
$8.11K Hold
100
0.01% 401
2023
Q1
$6.78K Hold
100
﹤0.01% 410
2022
Q4
$4.95K Hold
100
﹤0.01% 421
2022
Q3
$3K Hold
100
﹤0.01% 435
2022
Q2
$4K Hold
100
﹤0.01% 431
2022
Q1
$7K Hold
100
﹤0.01% 404
2021
Q4
$8K Hold
100
﹤0.01% 395
2021
Q3
$10K Hold
100
0.01% 369
2021
Q2
$12K Hold
100
0.01% 371
2021
Q1
$13K Hold
100
0.01% 359
2020
Q4
$13K Hold
100
0.01% 330
2020
Q3
$10K Hold
100
0.01% 336
2020
Q2
$9K Buy
+100
New +$7.99K 0.01% 350

Other funds holding EXAS

AllSquare Wealth Management's EXAS Position: Q3 2025 in Review

AllSquare Wealth Management held its Exact Sciences (EXAS) position steady in Q3 2025 at 100 shares worth $5.47K. The position accounts for ﹤0.01% of the portfolio, ranked #431.

AllSquare Wealth Management first reported a position in EXAS in Q2 2020 and has held it in 22 quarters since. The position peaked at $13K in Q1 2021. 567 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

  • AllSquare Wealth Management held 100 shares of Exact Sciences worth $5.47K as of Q3 2025.
  • AllSquare Wealth Management left its Exact Sciences share count unchanged in Q3 2025.
  • Exact Sciences made up ﹤0.01% of AllSquare Wealth Management's portfolio in Q3 2025, its #431 holding.
  • AllSquare Wealth Management first reported a position in Exact Sciences in Q2 2020 and has held it in 22 quarters since.
  • AllSquare Wealth Management's Exact Sciences position peaked at $13K in Q1 2021.
  • 567 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.